InsidersTradesSigma
Follow the Alzinova AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Alzinova AB has logged 42 insider filings. Market capitalisation: €205.9m. The latest transaction was filed on 26 June 2026 (Purchase). Among the most active insiders: Sebastian Hansson. The full history is free.
42
Insider Decl.
n/a
Thresholds
€377,638
31 ops.
Buy Volume
€34,283
2 ops.
Sell Volume
38Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 June 2026
Declarations42 total
90,000 shares@ SEK 0.52880.0040% mcap41.5% of flowAktieISIN SE0007413455FI:csv-60e419fb0e52fd0e0695
110,000 shares@ SEK 0.320.0047% mcap53.3% of flowAktieISIN SE0007413455FI:csv-c3d84feb209f69745cd3
110,000 shares0TeckningsoptionISIN SE0027620501FI:csv-13ce50cb6f1f7d66500a
9,375,000 shares@ SEK 0.020.024% mcap3.2% of flowTeckningsoptionISIN SE0027620501FI:csv-24a536224aa4b53631cf
9,375,000 shares@ SEK 0.020.025% mcap3.3% of flowTeckningsoptionISIN SE0027620501FI:A003Z720-1
29,316 shares0TeckningsoptionISIN SE0027620501FI:csv-db64f03edd87208e2e8e
29,316 shares@ SEK 0.320.0012% mcap10.4% of flowAktieISIN SE0007413455FI:csv-f65dd2d5e3d3af73ff47
78,386 shares0TeckningsoptionISIN SE0027620501FI:csv-f6477a1808fd6006b287
78,386 shares@ SEK 0.320.0032% mcap27.9% of flowAktieISIN SE0007413455FI:csv-e8df58adc826e8af8a14
78,386 shares@ €0.02940.0034% mcap28.8% of flowAktieISIN SE0007413455FI:A003Z281-1
29,316 shares@ €0.02940.0013% mcap10.8% of flowAktieISIN SE0007413455FI:A003Z282-1
41,666 shares@ SEK 0.120.0006% mcap5.6% of flowTeckningsoptionISIN SE0027620501FI:csv-fd2ed5f27c0b391d457d
49,025 shares@ SEK 0.120.0008% mcap100.0% of flowTeckningsoptionISIN SE0027620501FI:csv-4cdedaeef8c8cca7c746
49,025 shares@ €0.0110.0008% mcap9.0% of flowTeckningsoptionISIN SE0027620501FI:A003Z203-1
41,666 shares@ €0.01110.0007% mcap9.5% of flowTeckningsoptionISIN SE0027620501FI:A003Z222-1
50,000 shares@ SEK 0.1150.0007% mcap18.8% of flowTeckningsoptionISIN SE0027620501FI:csv-02b56321a8b85ccde0f1
50,000 shares@ €0.01060.0008% mcap2.2% of flowTeckningsoptionISIN SE0027620501FI:A003Z174-1
20,000 shares@ SEK 0.46450.0012% mcap10.3% of flowAktieISIN SE0007413455FI:csv-56ec4afbd3f8beecec17
23,057 shares@ SEK 0.46450.0014% mcap11.9% of flowAktieISIN SE0007413455FI:csv-dff153721929d1a1d791
20,000 shares@ €0.04280.0013% mcap19.5% of flowAktieISIN SE0007413455FI:A003Z110-1
23,057 shares@ €0.04280.0014% mcap22.5% of flowAktieISIN SE0007413455FI:A003Z108-1
50,000 shares@ SEK 0.500.0032% mcap81.2% of flowAktieISIN SE0007413455FI:csv-0a6f91ab5b92b78ffe19
50,000 shares@ €0.04570.0034% mcap9.6% of flowAktieISIN SE0007413455FI:A003Z007-1
40,000 shares@ €0.05480.0032% mcap10.2% of flowAktieISIN SE0007413455FI:A003X505-1
1,345,000 shares@ €0.22270.44% mcap58.8% of flowBTU (betald tecknad unit)ISIN SE0027620527FI:A003X091-1
25 of 42 declarations
关于 Alzinova AB
Alzinova AB 是一家生物制药公司，专注于开发神经退行性疾病，特别是阿尔茨海默病的治疗方法。该公司在斯德哥尔摩证券交易所 (XSTO) 上市。